Price$192.15+37.46 (+24.22%)
2026-03-042026-06-05
News · 26 weeks53-8%
2025-12-142026-06-07
Mix4490d
- Insider30(68%)
- Other6(14%)
- SEC Filings5(11%)
- Earnings2(5%)
- Analyst1(2%)
Latest news
25 items- INSIDERDirector Yale Phyllis R gifted 5,038 shares, decreasing direct ownership by 35% to 9,525 units (SEC Form 4)4 - DAVITA INC. (0000927066) (Issuer)
- INSIDERDirector Pullin Dennis W was granted 250 shares, increasing direct ownership by 10% to 2,671 units (SEC Form 4)4 - DAVITA INC. (0000927066) (Issuer)
- INSIDERDirector Schoppert Wendy Lee was granted 250 shares (SEC Form 4)4 - DAVITA INC. (0000927066) (Issuer)
- INSIDERDirector Moore Gregory J. was granted 250 shares, increasing direct ownership by 3% to 7,813 units (SEC Form 4)4 - DAVITA INC. (0000927066) (Issuer)
- INSIDERDirector Arway Pamela M was granted 250 shares, increasing direct ownership by 0.94% to 26,945 units (SEC Form 4)4 - DAVITA INC. (0000927066) (Issuer)
- INSIDERDirector Yale Phyllis R was granted 250 shares, increasing direct ownership by 2% to 14,563 units (SEC Form 4)4 - DAVITA INC. (0000927066) (Issuer)
- INSIDERDirector Hollar Jason M. was granted 250 shares, increasing direct ownership by 4% to 6,605 units (SEC Form 4)4 - DAVITA INC. (0000927066) (Issuer)
- INSIDERDirector Desoer Barbara J was granted 250 shares (SEC Form 4)4 - DAVITA INC. (0000927066) (Issuer)
- INSIDERDirector Schechter Adam H was granted 250 shares, increasing direct ownership by 5% to 5,692 units (SEC Form 4)4 - DAVITA INC. (0000927066) (Issuer)
- INSIDERChief Compliance Officer Hearty James O exercised 5,784 shares at a strike of $110.63, returned $640,061 worth of shares to the company (3,231 units at $198.10), covered exercise/tax liability with 1,117 shares and sold $2,909,745 worth of shares (15,000 units at $193.98), decreasing direct ownership by 38% to 22,389 units (SEC Form 4) to satisfy withholding obligation4 - DAVITA INC. (0000927066) (Issuer)
- PRDaVita Sets Bold 2030 Community Care Commitments After Exceeding Prior Five-Year ESG GoalsKidney care leader launches its next chapter of measurable impact for patients, teammates, and communities.DENVER, May 18, 2026 /PRNewswire/ -- DaVita today announced its 2030 Community Care commitments, a new set of long-term goals, focused on improving patient outcomes, supporting the expansion of economic opportunity for teammates, and strengthening community and environmental resilience. The announcement follows the company achieving or exceeding the majority of its prior five-year environmental, social, and governance (ESG) goals, reinforcing DaVita's track record of turning ambition into measurable impact.Guided by its Trilogy of Care—Caring for Our Patients, Caring for Each Other and
- INSIDERChief Operating Officer, DKC Maughan David Paul sold $4,089,743 worth of shares (20,529 units at $199.22), decreasing direct ownership by 18% to 94,105 units (SEC Form 4)4 - DAVITA INC. (0000927066) (Issuer)
- INSIDERCFO and Treasurer Ackerman Joel sold $9,887,528 worth of shares (51,471 units at $192.10), decreasing direct ownership by 28% to 132,434 units (SEC Form 4)4 - DAVITA INC. (0000927066) (Issuer)
- INSIDERChief Compliance Officer Hearty James O sold $381,916 worth of shares (2,184 units at $174.87) as part of a pre-agreed trading plan, decreasing direct ownership by 6% to 35,953 units (SEC Form 4)4 - DAVITA INC. (0000927066) (Issuer)
- SECSEC Form 144 filed by DaVita Inc.144 - DAVITA INC. (0000927066) (Subject)
- ANALYSTDaVita upgraded by Deutsche Bank with a new price targetDeutsche Bank upgraded DaVita from Hold to Buy and set a new price target of $220.00
- SECSEC Form 10-Q filed by DaVita Inc.10-Q - DAVITA INC. (0000927066) (Filer)
- SECDaVita Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - DAVITA INC. (0000927066) (Filer)
- PRDaVita Inc. 1st Quarter 2026 ResultsDENVER, May 5, 2026 /PRNewswire/ -- DaVita Inc. (NYSE:DVA) announced financial and operating results for the quarter ended March 31, 2026."DaVita's foundation is clinical excellence, driven by operating rigor that produces durable results," said Javier Rodriguez, CEO of DaVita Inc. "We have consistently delivered exceptional clinical outcomes and strong financial performance, and this quarter is no exception."Financial and operating highlights for the quarter and year ended March 31, 2026:Consolidated revenues were $3.416 billion.Operating income was $482 million.Diluted earnings per share from continuing operations was $2.87.Operating cash flow was $321 million and free cash flow was $140 m
- PRHoneywell Announces Board of Directors for Honeywell AerospaceDirectors bring compelling mix of aerospace and defense expertise, leadership experience, and financial and capital markets backgroundsHoneywell spin-off of Honeywell Aerospace expected to be completed on June 29, 2026Management will provide details on Honeywell Aerospace's value creation and financial outlook at an Investor Day on June 3, 2026 CHARLOTTE, N.C., April 28, 2026 /PRNewswire/ -- Honeywell (NASDAQ:HON) today announced the anticipated Board of Directors for Honeywell Aerospace, which will be one of the largest publicly listed pure-play aerospace and defense companies following its planned spin-off from Honeywell.
- SECSEC Form DEFA14A filed by DaVita Inc.DEFA14A - DAVITA INC. (0000927066) (Filer)
- SECSEC Form DEF 14A filed by DaVita Inc.DEF 14A - DAVITA INC. (0000927066) (Filer)
- PRDaVita Inc. Schedules 1st Quarter 2026 Investor Conference CallDENVER, April 20, 2026 /PRNewswire/ -- DaVita Inc. (NYSE:DVA), announced today that it will hold its quarterly conference call to discuss first quarter results on Tuesday, May 5, 2026, at 5:00 p.m. Eastern Time. The company plans to release its results after market close the same day.This call is also being webcast and can be accessed at the DaVita IR web page. You can join this call as follows: Tuesday, May 5, 2026 Starting at 5:00 p.m. EDTWebcast can be accessed using this link Dial in number: 877-918-6630International dial in: 517-308-9042When calling in, please provide the operator the password "Earnings" and provide your name and company affiliation. Investors unable to listen to the co
- SECAmendment: SEC Form SCHEDULE 13G/A filed by DaVita Inc.SCHEDULE 13G/A - DAVITA INC. (0000927066) (Subject)
- PRDaVita Highlights Continued Progress in Value-Based Kidney Care as CKCC Results Show Year-Over-Year ImprovementDisclaimer: The statements contained in this document are solely those of the authors and do not necessarily reflect the views or policies of CMS. The authors assume responsibility for the accuracy and completeness of the information contained in this document.DENVER, March 18, 2026 /PRNewswire/ -- DaVita today highlighted continued progress in value-based kidney care, underscoring how sustained investment in coordinated care models is translating into improved outcomes for people living with kidney disease. That progress is evident across both industry partnerships with major insurers and scaled programs sponsored by the Center for Medicare & Medicaid Innovation (CMMI).For more than two dec
DVA FAQ
6 questionsWhat does DaVita Inc. do?
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease (ESRD). The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company provides disease...Where does DVA stock trade?
DaVita Inc. (DVA) is listed on NYSE.What sector and industry is DVA in?
DaVita Inc. operates in the Health Care sector, Misc Health and Biotechnology Services industry.What are analysts saying about DVA?
DaVita Inc. has had 8 recent analyst actions on file. The most recent action was from Deutsche Bank: Buy on 2026-05-06.What companies are similar to DVA?
Notable peers in the same industry include FMS (Fresenius Medical Care AG), SHC (Sotera Health Company), PGNY (Progyny Inc.), AGL (agilon health inc.), VMD (Viemed Healthcare Inc.). Compare DVA side-by-side with any of them on Quantisnow.How can I track DVA on Quantisnow?
Quantisnow aggregates DaVita Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow DVA to receive live email and push alerts on every new disclosure.